Prognostic factors of pulmonary exacerbations severity in pediatric bronchiectasis: a retrospective cohort study

Author:

Ali Heba A.ORCID,Salem Mona A.,Abdelwahad Marwa A.

Abstract

Abstract Background Pulmonary exacerbations have been found to negatively impact the natural course of pediatric bronchiectasis. However, prognostic factors that might predict the severity of exacerbations are poorly identified. Therefore, this study was designed to identify the best prognostic factors associated with pulmonary exacerbations severity in pediatric bronchiectasis. Results This retrospective cohort study involved fifty stable bronchiectasis patients including cystic fibrosis (CF) and non-CF bronchiectasis under the age of 18 years. The pulmonary exacerbations during the previous year were reviewed among the studied patients determining their relations with bacterial colonization, inflammatory markers, lung function, and severity scores. The severity of pulmonary exacerbations was directly related to the number of hospitals and ICU admissions (P < 0.001, P < 0.001), exacerbations frequency (P < 0.001), SPEX score (P = 0.002), inflammatory markers as sputum neutrophil elastase (P < 0.001), C-reactive protein (CRP) (P < 0.001), Respiratory and Systemic Symptoms Questionnaire (RSSQ) (P < 0.001), Acute Respiratory Illness Checklist (ARIC) (P < 0.001), cough severity score (P < 0.001), and bronchiectasis severity index (BSI) (P = 0.009) in all bronchiectasis patients. Additional significant relations were found between exacerbations severity with pseudomonas colonization and FACED score (P = 0.002, P = 0.010) among CF patients and with lower body mass index (BMI) and older age (P = 0.035, P < 0.001) among non-CF bronchiectasis patients respectively. Conclusions Pulmonary exacerbations are prevalent among both pediatric CF and non-CF bronchiectasis patients. In this population, the best prognostic factors for pulmonary exacerbation severity were the frequency of ICU admissions and BSI more than 11 identifying their importance during bronchiectasis assessment.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3